| abstract |
The present invention relates to a composition comprising a glucose-regulating peptide linked to an extended recombinant polypeptide (XTEN), an isolated nucleic acid encoding the composition, a vector and host cell comprising the same, and the production of such a composition. The invention relates to the use of these compositions in the treatment of glucose-regulating peptide-related diseases, disorders and conditions. The present disclosure is directed to compositions and methods that may be useful in the treatment of any disease, disorder, or condition that is ameliorated, ameliorated, or inhibited by administering a glucose-regulating peptide. . |